Leerink Global Healthcare Conference 2026
Logotype for DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) Leerink Global Healthcare Conference 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for DENTSPLY SIRONA Inc

Leerink Global Healthcare Conference 2026 summary

10 Mar, 2026

Strategic priorities and progress tracking

  • Focus on urgency and day-to-day progress, with key metrics around dealer engagement and clinical education volume as leading indicators for U.S. business health.

  • Simplified dealer relationships and dropship models aim to improve efficiency, cash flow, and inventory management.

  • Emphasis on transparent communication, bold decision-making, and holistic business health over short-term profitability.

  • Restructuring and investments are expected to create near-term EPS pressure, with anticipated benefits in the second half of the year.

  • Plans to de-leverage and use cash flow for share repurchases to drive EPS growth.

Product and innovation strategy

  • Incremental R&D is now strategically focused, accelerating DS Core software development across multiple verticals and modernizing the EDS portfolio.

  • AI and robotics are being integrated into product development and workflow enhancements, with AI also targeted for internal efficiency gains.

  • Primescan 3 is in conceptual stages, aiming for smaller, faster, and more affordable intraoral scanners.

  • SureSmile orthodontic platform is being modernized, with R&D focused on software upgrades and clinical education to regain market share.

  • No significant product gaps identified; execution and communication are the main areas for improvement.

Commercial and market execution

  • Renewed dealer partnerships and simplified deal structures are designed to align incentives and drive volume.

  • Clinical education and rep training are prioritized, especially for implants and ortho, with a med device-style approach to rep development.

  • DSO (Dental Service Organization) strategy is being sequenced, with a dedicated team and structure expected in the next six months.

  • Promotional partnerships with dealers are favored, provided there are volume commitments to justify price relief.

  • EMEA is the strongest region for implants, with Asia Pacific seen as the highest potential growth market.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more